{"id":"https://openalex.org/W1998449556","doi":"https://doi.org/10.1054/bjoc.2000.1631","title":"A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer","display_name":"A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer","publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W1998449556","doi":"https://doi.org/10.1054/bjoc.2000.1631","mag":"1998449556","pmid":"https://pubmed.ncbi.nlm.nih.gov/11207039","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2363773"},"language":"en","primary_location":{"id":"doi:10.1054/bjoc.2000.1631","doi":"https://doi.org/10.1054/bjoc.2000.1631","is_oa":true,"landing_page_url":"https://doi.org/10.1054/bjoc.2000.1631","pdf_url":"https://www.nature.com/articles/6691631.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/6691631.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042028913","display_name":"Stefano Cascinu","orcid":"https://orcid.org/0000-0003-2215-0731","observed_orcids":["https://orcid.org/0000-0003-2215-0731"]},"institutions":[{"id":"https://openalex.org/I4210135416","display_name":"Ospedale di Parma","ror":"https://ror.org/03jg24239","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210135416"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S Cascinu","raw_affiliation_strings":["Division of Medical Oncology, Azienda Ospedale di Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Azienda Ospedale di Parma, Italy","institution_ids":["https://openalex.org/I4210135416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018141422","display_name":"Francesco Graziano","orcid":"https://orcid.org/0000-0002-4896-1842","observed_orcids":["https://orcid.org/0000-0002-4896-1842","https://orcid.org/0009-0003-5750-0559"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Graziano","raw_affiliation_strings":["Medical Oncology Unit, Azienda Ospedale di Urbino, Italy","Medical Oncology Unit, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Azienda Ospedale di Urbino, Italy","institution_ids":[]},{"raw_affiliation_string":"Medical Oncology Unit, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061179981","display_name":"Sandro Barni","orcid":"https://orcid.org/0000-0002-7633-0378","observed_orcids":["https://orcid.org/0000-0002-7633-0378"]},"institutions":[{"id":"https://openalex.org/I4210161395","display_name":"Azienda Ospedaliera Treviglio","ror":"https://ror.org/05rv6z116","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210161395"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S Barni","raw_affiliation_strings":["Division of Medical Oncology, Azienda Ospedale di Treviglio, Italy","Division of Medical Oncology, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Azienda Ospedale di Treviglio, Italy","institution_ids":["https://openalex.org/I4210161395"]},{"raw_affiliation_string":"Division of Medical Oncology, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084773667","display_name":"Roberto Labianca","orcid":"https://orcid.org/0000-0001-7149-822X","observed_orcids":["https://orcid.org/0000-0001-7149-822X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Labianca","raw_affiliation_strings":["Medical Oncology Unit, Azienda Ospedale di Bergamo, Italy","Medical Oncology Unit, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Azienda Ospedale di Bergamo, Italy","institution_ids":[]},{"raw_affiliation_string":"Medical Oncology Unit, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110124509","display_name":"G. Comella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G Comella","raw_affiliation_strings":["National Tumor Institute, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Tumor Institute, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036443897","display_name":"Rossana Casaretti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"R Casaretti","raw_affiliation_strings":["National Tumor Institute, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Tumor Institute, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":null,"display_name":"L Frontini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086830","display_name":"Ospedale San Paolo","ror":"https://ror.org/0026m8b31","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I4210086830"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"L Frontini","raw_affiliation_strings":["Medical Oncology Unit, Ospedale San Paolo, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Ospedale San Paolo, Milan, Italy","institution_ids":["https://openalex.org/I4210086830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038347927","display_name":"Vincenzo Catalano","orcid":"https://orcid.org/0000-0002-8380-7736","observed_orcids":["https://orcid.org/0000-0002-8380-7736"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Catalano","raw_affiliation_strings":["Division of Medical Oncology, Azienda Ospedale di Pesaro, Italy","Division of Medical Oncology, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Azienda Ospedale di Pesaro, Italy","institution_ids":[]},{"raw_affiliation_string":"Division of Medical Oncology, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111873146","display_name":"Anna Maria Baldelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A M Baldelli","raw_affiliation_strings":["Division of Medical Oncology, Azienda Ospedale di Pesaro, Italy","Division of Medical Oncology, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Azienda Ospedale di Pesaro, Italy","institution_ids":[]},{"raw_affiliation_string":"Division of Medical Oncology, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067058355","display_name":"Giuseppina Catalano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Catalano","raw_affiliation_strings":["Division of Medical Oncology, Azienda Ospedale di Pesaro, Italy","Division of Medical Oncology, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Azienda Ospedale di Pesaro, Italy","institution_ids":[]},{"raw_affiliation_string":"Division of Medical Oncology, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":2.9682,"has_fulltext":true,"cited_by_count":47,"citation_normalized_percentile":{"value":0.90776332,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"84","issue":"4","first_page":"470","last_page":"474"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-gastric-cancer","display_name":"advanced gastric cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8180000185966492},{"id":"https://openalex.org/keywords/weekly-chemotherapy","display_name":"weekly chemotherapy","score":0.6050000190734863},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9259999990463257},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.8799999952316284},{"id":"https://openalex.org/keywords/epidoxorubicin","display_name":"epidoxorubicin","score":0.8709999918937683},{"id":"https://openalex.org/keywords/leucovorin","display_name":"leucovorin","score":0.9610000252723694},{"id":"https://openalex.org/keywords/filgrastim","display_name":"filgrastim","score":0.9789999723434448},{"id":"https://openalex.org/keywords/sequential-chemotherapy","display_name":"sequential chemotherapy","score":0.8169999718666077},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6579999923706055},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9760000109672546},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.7070000171661377},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8752509355545044},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8232723474502563},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7141419649124146},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6942955851554871},{"id":"https://openalex.org/C2779171977","wikidata":"https://www.wikidata.org/wiki/Q3151081","display_name":"Filgrastim","level":4,"score":0.6729301810264587},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6718495488166809},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6559511423110962},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5544084906578064},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.5137425661087036},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.45737576484680176},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.45433998107910156},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42500829696655273},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3385162353515625}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005978","descriptor_name":"Glutathione","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013921","descriptor_name":"Thrombocytopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1054/bjoc.2000.1631","doi":"https://doi.org/10.1054/bjoc.2000.1631","is_oa":true,"landing_page_url":"https://doi.org/10.1054/bjoc.2000.1631","pdf_url":"https://www.nature.com/articles/6691631.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:1506664","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2363773","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2363773","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2363773","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:11207039","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11207039","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial"},{"id":"pmh:oai:iris.univpm.it:11566/71587","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11566/71587","pdf_url":"https://iris.univpm.it/bitstream/11566/71587/1/unpaywall-bitstream-813935617.pdf","source":{"id":"https://openalex.org/S4306402571","display_name":"Universit\u00e0 Politecnica delle Marche (Universit\u00e0 Politecnica delle Marche)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I122534668","host_organization_name":"Marche Polytechnic University","host_organization_lineage":["https://openalex.org/I122534668"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1054/bjoc.2000.1631","doi":"https://doi.org/10.1054/bjoc.2000.1631","is_oa":true,"landing_page_url":"https://doi.org/10.1054/bjoc.2000.1631","pdf_url":"https://www.nature.com/articles/6691631.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1998449556.pdf","grobid_xml":"https://content.openalex.org/works/W1998449556.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W113401881","https://openalex.org/W1843791750","https://openalex.org/W1863712471","https://openalex.org/W1974734959","https://openalex.org/W2001566158","https://openalex.org/W2017997921","https://openalex.org/W2029409133","https://openalex.org/W2033928892","https://openalex.org/W2046580132","https://openalex.org/W2111513457","https://openalex.org/W2139505545","https://openalex.org/W2167805334","https://openalex.org/W2170346929","https://openalex.org/W2261751141","https://openalex.org/W4233628679"],"related_works":["https://openalex.org/W2012143033","https://openalex.org/W2065619958","https://openalex.org/W2351263191","https://openalex.org/W2093261308","https://openalex.org/W2335026966","https://openalex.org/W2230249517","https://openalex.org/W2376280796","https://openalex.org/W2390333244","https://openalex.org/W2105071689","https://openalex.org/W2348123719"],"abstract_inverted_index":{"In":[0],"advanced":[1],"gastric":[2,34],"cancer,":[3],"we":[4],"investigated":[5],"feasibility":[6],"and":[7,57,97,103,124,154,197,213,218,232],"activity":[8],"of":[9,20,40,53,85,204,221,238,254,260],"sequential":[10,236],"chemotherapy":[11,41,242],"with":[12,30,42,76,148,157,247],"docetaxel":[13,86,233,239],"after":[14,240],"an":[15],"intensive":[16],"weekly":[17,38],"regimen":[18,180],"consisting":[19],"cisplatin,":[21],"epidoxorubicin,":[22],"fluorouracil,":[23],"leucovorin":[24,54],"(PELF)":[25],"plus":[26],"filgrastim.":[27],"Chemotherapy-naive":[28],"patients":[29,75,93,110,115,120,126,141,147,156,170],"relapsed":[31],"or":[32,79,262],"metastatic":[33],"cancer":[35],"received":[36,82],"8":[37],"administrations":[39],"cisplatin":[43],"40":[44,92,169],"mg/m(2),":[45,48,51],"fluorouracil":[46],"500":[47],"epidoxorubicin":[49],"35":[50],"6S-stereoisomer":[52],"250":[55],"mg/m(2)":[56,88],"glutathione":[58],"1.5":[59],"g/m(2).":[60],"On":[61],"the":[62,106,143,168,188,202,216,219,258],"other":[63],"days":[64],"filgrastim":[65],"5":[66],"microg":[67],"kg(-1)":[68],"was":[69,171,225],"administered":[70],"by":[71],"subcutaneous":[72],"injection.":[73],"Subsequently,":[74],"partial":[77,117,152,158],"response":[78,102,129,153,159,165],"stable":[80,122,149],"disease":[81,123,150],"3":[83,90,109,125],"cycles":[84,222],"100":[87],"every":[89],"weeks.":[91],"have":[94],"been":[95],"enrolled":[96],"they":[98],"are":[99],"evaluable":[100],"for":[101],"toxicity.":[104,249],"After":[105,136],"PELF":[107,179,206,231,241],"regimen,":[108],"achieved":[111,151,160],"complete":[112,161],"response,":[113,118],"13":[114],"showed":[116],"21":[119],"had":[121],"progressed":[127],"(40%":[128],"rate;":[130],"95%":[131],"CI":[132],"25%":[133],"to":[134,176],"55%).":[135],"docetaxel,":[137],"9":[138],"out":[139],"34":[140],"improved":[142],"outcome":[144],"(26.5%);":[145],"7":[146],"2":[155],"response.":[162],"The":[163,178,235],"overall":[164],"rate":[166],"in":[167,201,215,257],"57.5%":[172],"(95%":[173],"CI,":[174],"42.5%":[175],"72.5%).":[177],"did":[181],"not":[182],"cause":[183],"any":[184],"grade":[185,191,210],"IV":[186],"toxicity,":[187],"most":[189],"frequent":[190,227],"III":[192],"acute":[193],"side-effects":[194],"were":[195],"thrombocytopenia":[196,214],"vomiting":[198],"which":[199],"occurred":[200],"10%":[203,217],"320":[205],"cycles.":[207],"Docetaxel":[208],"caused":[209],"III-IV":[211],"neutropenia":[212],"19%":[220],"respectively.":[223],"Fatigue":[224],"a":[226],"side-effect":[228],"during":[229],"both":[230],"chemotherapy.":[234,264],"application":[237],"gained":[243],"major":[244],"objective":[245],"responses":[246],"manageable":[248],"This":[250],"strategy":[251],"is":[252],"worth":[253],"further":[255],"investigation":[256],"setting":[259],"palliative":[261],"neoadjuvant":[263]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}